申请人:Jain Rajendra Parasmal
公开号:US20120136008A1
公开(公告)日:2012-05-31
New heterocyclic compounds that may be used to modulate a histamine receptor in an individual are described. Pyrido[4,3-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
本文介绍了一种新型杂环化合物,可以用于调节个体中的组胺受体。其中包括吡啶并[4,3-b]吲哚类化合物,还包括含有这些化合物的药物组合物以及使用这些化合物进行多种治疗应用的方法,包括治疗认知障碍、精神障碍、神经递质介导的疾病和/或神经元疾病。